Ahn, J.-Y.; Lim, D.-W.; Kim, J.-H.; Park, S.-Y.; Park, S.-D.; Lee, J.-H.
Sinhyotaklisan as a Potential Therapeutic for Psoriasis: Network Pharmacology and Experimental Validation. Int. J. Mol. Sci. 2025, 26, 5082.
https://doi.org/10.3390/ijms26115082
AMA Style
Ahn J-Y, Lim D-W, Kim J-H, Park S-Y, Park S-D, Lee J-H.
Sinhyotaklisan as a Potential Therapeutic for Psoriasis: Network Pharmacology and Experimental Validation. International Journal of Molecular Sciences. 2025; 26(11):5082.
https://doi.org/10.3390/ijms26115082
Chicago/Turabian Style
Ahn, Jung-Yun, Dong-Woo Lim, Jin-Hee Kim, Sung-Yun Park, Sun-Dong Park, and Ju-Hee Lee.
2025. "Sinhyotaklisan as a Potential Therapeutic for Psoriasis: Network Pharmacology and Experimental Validation" International Journal of Molecular Sciences 26, no. 11: 5082.
https://doi.org/10.3390/ijms26115082
APA Style
Ahn, J.-Y., Lim, D.-W., Kim, J.-H., Park, S.-Y., Park, S.-D., & Lee, J.-H.
(2025). Sinhyotaklisan as a Potential Therapeutic for Psoriasis: Network Pharmacology and Experimental Validation. International Journal of Molecular Sciences, 26(11), 5082.
https://doi.org/10.3390/ijms26115082